GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starpharma Holdings Ltd (OTCPK:SPHRY) » Definitions » Price-to-Funds-From-Operations

Starpharma Holdings (Starpharma Holdings) Price-to-Funds-From-Operations : (As of May. 17, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Starpharma Holdings Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Starpharma Holdings (Starpharma Holdings) Business Description

Traded in Other Exchanges
Address
4-6 Southampton Crescent, Abbotsford, Melbourne, VIC, AUS, 3067
Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating and VIRALEZE an antiviral nasal spray.